Skip to main content
International Journal of Preventive Medicine logoLink to International Journal of Preventive Medicine
letter
. 2013 May;4(5):618–619.

Commentary on: Effects of Cinnamon Consumption on Glycemic Status, Lipid Profile and Body Composition in Type 2 Diabetic Patients

Hamid Nasri 1,, Yahya Madihi 1, Alireza Marikhi 1
PMCID: PMC3733197  PMID: 23930177

DEAR EDITOR,

The recently published article by Vafa et al., entitled “effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients” in the esteemed Journal of Int J Prev Med had some interesting points, needs to explain more. In a double blind, randomized, placebo controlled clinical trial, which was conducted on 44 patients with type 2 diabetes, they, observed that, in the treatment group, the levels of fasting blood glucose, HbA1c, triglyceride, weight, body mass index and body fat mass decreased significantly compared to baseline. They suggested that cinnamon may have a moderate effect in improving glycemic status,[1] a finding that was in accord with the study of Mishra et al. too.[2] Recently in the study of Ullah et al., daily dose of cinnamon (200 mg/kg) was employed alone and in combination with gentamicin for a period of 21 days in rabbits. They observed that cinnamon significantly attenuated gentamicin-kidney toxicity by assessing the urea, creatinine, uric acid, urinary protein, and histopathological study of the kidneys. They suggested that cinnamon have strong kidney protective properties, especially against aminoglycosides.[3] Today, the clinical use of aminoglycosides is limited to special conditions. However, gentamicin as a well-known aminoglycoside can be used as a model to study of acute kidney injury in experimental animal models.[4,5,6] Thus, cinnamon might have renal protective effects in the conditions, acts like aminoglycoside renal toxicity. Various investigations containing our previous studies have shown that antioxidant agents satisfactory, inhibited or ameliorated gentamicin nephrotoxicity in the rat model.[7,8] Hence, it seems that cinnamon, have two distinct efficacy, protecting the renal tubular cells injurious substances and secondly blood glucose regulating property. While, nephropathy is one of the most important complications of diabetes mellitus,[9,10,11,12] thus using antioxidants especially safe herbal medicines is a useful adjunctive therapy.[13,14] Indeed, diabetes kidney disease is the result of injury to the glomeruli and tubulointerstitium, as well.[15,16,17,18,19] Thus cinnamon may have synergistic effects to exert its renoprotection in diabetic patients. In this regard, to better understand the cinnamon renoprotective properties, more experimental rat models or clinical studies are suggested.

Footnotes

Source of Support: University of West London, UK

Conflict of Interest: None declared

REFERENCES

  • 1.Vafa M, Mohammadi F, Shidfar F, Sormaghi MS, Heidari I, Golestan B, et al. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med. 2012;3:531–6. [PMC free article] [PubMed] [Google Scholar]
  • 2.Mishra A, Bhatti R, Singh A, Singh Ishar MP. Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med. 2010;76:412–7. doi: 10.1055/s-0029-1186237. [DOI] [PubMed] [Google Scholar]
  • 3.Ullah N, Khan MA, Khan T, Ahmad W. Bioactive traditional plant Cinnamomum zeylanicum successfully combat against nephrotoxic effects of aminoglycosides. Bangladesh J Pharmacol. 2013;8:15–21. [Google Scholar]
  • 4.Tavafi M. Inhibition of gentamicin-induced renal tubular cell necrosis. J Nephropathology. 2012;1:83–6. doi: 10.5812/nephropathol.7512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathology. 2012;1:81–2. doi: 10.5812/nephropathol.7475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Rafieian-Kopaei M, Nasri H, Nematbakhsh M, Baradaran A, Gheissari A, Rouhi H, et al. Erythropoietin ameliorates gentamicin-induced renal toxicity: A biochemical and histopathological study. J Nephropathology. 2012;1:109–16. doi: 10.5812/nephropathol.7533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Amini FG, Rafieian-Kopaei M, Nematbakhsh M, Baradaran A, Nasri H. Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin–induced renal toxicity in Wistar rats. J Res Med Sci. 2012;17:621–5. [PMC free article] [PubMed] [Google Scholar]
  • 8.Rafieian-Kopaei M, Baradaran A, Merrikhi A, Nematbakhsh M, Madihi Y, Nasri H. Efficacy of co-administration of garlic extract and metformin for prevention of gentamicin–renal toxicity in wistar rats: A biochemical study. Int J Prev Med. 2013;4:258–64. [PMC free article] [PubMed] [Google Scholar]
  • 9.Tolouian R, Hernandez GT. Prediction of diabetic nephropathy: The need for a sweet biomarker. J Nephropathology. 2013;2:4–5. doi: 10.5812/nephropathol.8966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathology. 2012;1:143–51. doi: 10.5812/nephropathol.8109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Rouhi H, Ganji F. Effect of n-acetyl cysteine on serum lipoprotein(a) and proteinuria in type 2 diabetic patients. J Nephropathology. 2013;1:61–6. doi: 10.5812/nephropathol.8940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Baradaran A. Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathology. 2012;1:126–9. doi: 10.5812/nephropathol.8107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathology. 2013;2:20–7. doi: 10.5812/nephropathol.9093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Khajehdehi P. Turmeric: Reemerging of a neglected Asian traditional remedy. J Nephropathology. 2012;1:17–22. doi: 10.5812/jnp.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gheissari A, Javanmard SH, Shirzadi R, Amini M, Khalili N. The effects of blocking Angiotensin receptors on early stages of diabetic nephropathy. Int J Prev Med. 2012;3:477–82. [PMC free article] [PubMed] [Google Scholar]
  • 16.Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathology. 2012;1:177–82. doi: 10.5812/nephropathol.8119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathology. 2012;1:101–8. doi: 10.5812/nephropathol.7534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nematbakhsh M, Pezeshki Z, Moaeidi B, Eshraghi-Jazi F, Talebi A, Nasri H, et al. Protective role of silymarin and deferoxamine against iron dextran-Induced renal iron deposition in male rats. Int J Prev Med. 2013;4:286–91. [PMC free article] [PubMed] [Google Scholar]
  • 19.Akilen R. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med. 2013;4:379–80. [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Preventive Medicine are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES